Amarin | AMRN - Reddito Netto





Reddito Netto Cambiamento Data
AbbVie USD 4.22B 605M 2026-09
Alnylam Pharmaceuticals USD 2.17B 2B 2026-09
Amarin USD -1.22M 6.51M 2025-12
AstraZeneca USD 3.12B 610M 2026-09
BioCryst Pharmaceuticals USD 78.4M 167.45M 2026-06
DBV Technologies USD -64.5M 16.9M 2026-09
GlaxoSmithKline GBP 1.54B 1.11B 2026-09
Halozyme Therapeutics USD 247.05M 17.14M 2026-09
Heron Therapeutics USD -2.95M 14.54M 2025-12
Ionis Pharmaceuticals USD -87M 27.65M 2026-09
Nektar Therapeutics USD -44.9M 8.82M 2026-03
Neurocrine Biosciences USD 206.5M 62.1M 2026-09
Novartis USD 1.2B 2.06B 2026-09